hVIVO plc (LON:HVO – Get Free Report)’s share price rose 10.3% during trading on Monday . The company traded as high as GBX 21.50 ($0.27) and last traded at GBX 21.31 ($0.27). Approximately 3,194,943 shares were traded during trading, an increase of 18% from the average daily volume of 2,705,167 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Performance
The stock has a 50-day moving average price of GBX 20.36 and a 200 day moving average price of GBX 25.73. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The firm has a market capitalization of £145.01 million, a price-to-earnings ratio of 710.47 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 5 Space Stocks to Watch as the Industry Reaches New Heights
- What is the FTSE 100 index?
- MP Materials: Rare Earth Elements Powering the EV Boom
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
